Dr. Daniel B. Goldberg, a prominent New Jersey ophthalmologist and president of the Ranney School Board of Trustees, has been hailed by Premier Surgeon as one of 250 leading innovative surgeons in North America in the field of premium IOL (Intraocular Lens) implant surgery. He was among a distinguished roster of surgeons that appeared in the publication’s March/April inaugural issue.

An ophthalmologist specializing in comprehensive refractive surgery including LASIK eye surgery and cataract surgery, Dr. Goldberg, a Rumson resident, is principal of Atlantic Eye Physicians with offices in Little Silver, Long Branch and Holmdel. Voted one of the best eye doctors in America by his peers, he was named one of New Jersey’s top doctors by New Jersey Monthly. With 25 years of experience in refractive surgery, Dr. Goldberg is considered a pioneer in laser vision correction in the Garden State. He was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages which led to FDA approval. A frequent lecturer, Dr. Goldberg has also published original research to advance laser treatments. He received his undergraduate degree from the University of California, Berkeley and his M.D. degree from the State University of New York.

Premier Surgeon is a definitive resource for refractive cataract surgeons who wish to provide unparalled patient care and outcomes and who strive to be market leaders in the arena of premium IOLs.

Phakic IOLs are known to have minimal impact on higher-order aberrations of the optical wavefront. Might this characteristic give soldiers with phakic IOLs a visual advantage in combat, compared to wavefront-optimized LASIK?
U.S. Army Maj. Gregory D. Parkhurst, MD, chief of refractive surgery at the Darnall Army Medical Center at Fort Hood, Tex., has been investigating this question. He says early hints suggest the answer might be yes.

(Dr. Parkhurst agreed to talk about his early results, but he emphasized in his interview with Refractive Surgery Outlook that he was giving his personal opinions as a physician, and was not speaking for the military.)

“Today, excimer lasers with wavefront-corrected ablation profiles produce excellent visual acuity for patients. We’re hitting 20/20 post-op acuities almost all the time. So now the issue is quality of vision, an area where phakic IOLs excel,” said U.S. Army Maj. Gregory D. Parkhurst, MD, chief of refractive surgery at the Darnall Army Medical Center at Fort Hood, Tex.

Early Verdict: Safe for Soldiers

Based on a retrospective study of results in 104 active-duty military personnel (206 eyes), Dr. Parkhurst concluded earlier this year that the Visian Implantable Collamer Lens (ICL, Staar) is a safe, predictable refractive surgery option for military personnel who are not candidates for laser vision correction.

In the fall, he hopes to present the results of a Fort Hood study that tested soldiers’ visual acuities with a tool that mimics the low luminance of “night vision goggles” (Rabin Super Vision Test, Premiere Vision). Although he could not give specific details, Dr. Parkhurst spoke generally about the prospective study’s results.

In 25 carefully matched pairs of patients (pre-op sphere: -3D to -9D), a preliminary analysis suggests that the subjects with bilateral ICLs had better low-contrast UCVA than patients who had undergone wavefront-optimized LASIK (Allegretto Wave Eye-Q Excimer Laser, Alcon). This appeared to be the case with and without the simulated night vision goggles.

The differences in low-contrast acuity were small—approximately two to three letters on a logMAR chart. They were detectable and statistically significant, but their visual significance to soldiers on the battle field and other professionals requiring excellent quality of vision, such as police officers and professional athletes, remains to be shown, he said.

Small Differences in HOAs

“These are very small differences in HOAs between the ICL and LASIK eyes,” Dr. Parkhurst said. “The highest bar on my chart shows 0.45 microns of induced higher- order aberrations. That is a really low number. For example, in LASIK we don’t usually consider doing a custom ablation on a patient if pre-op HOAs are 0.4 microns or less.

“There’s something about the quality of vision with this lens that is much better than laser vision correction,” Dr. Parkhurst said. “Due to word of mouth we’re getting to the point that soldiers are now asking for ICLs as their first option, even when their corneas have no extra risk factors from LASIK or PRK. An OR nurse last week told me he was approached when he was out shopping at the commissary and asked about how to get on the list for a collamer lens.”
Dr. Parkhurst and other Army refractive surgeons at bases around the country are discussing the possibility of larger, multicenter clinical trials to investigate the quality of vision with ICLs further.

Abundance of Caution

“We’re going slowly, trying not to be too aggressive,” he said. “The next study needs to be a randomized, multicenter, controlled study in patients with normal eyes that could have LASIK if they chose. We need this to reassure us that if someone gets an ICL instead of LASIK, they’re not subject to greater complications.”

Dr. Parkhurst’s department is on pace this year to perform about 6,000 refractive surgeries on military personnel for whom lost or broken eyeglasses can be a life-or- death situation.

Concerns about flap displacement during combat have made PRK the most common procedure (60 percent). About 25 percent have LASIK and the rest opt for a single type of phakic IOL, the Visian ICL, because of its small incision size and position in the posterior chamber, he said.

Key Concern: Globe Trauma

The U.S. Army has been cautious about embracing phakic IOLs for its soldiers out of concern that the lens might not be stable or safe during combat trauma. Then in 2008, McCauley et al. reported on a soldier whose phakic IOL remained stable despite a grenade attack, orbital shrapnel and blunt globe trauma. [1]

“That case was considered evidence that the ICL would be stable despite traumatic globe injuries,” Dr. Parkhurst said. “So the Army okayed a program of using the ICL in candidates with thin corneas or other contraindications to laser vision correction. Our program at Fort Hood was one of the first.”

His department’s initial study on 206 eyes of 104 patients found that 100 percent of eyes with three months follow-up (n=139) were within 1.0 D of the refractive target; 89 percent were within 0.5 D.

ICL Safety in 104 Patients

UCVA was at least 20/15 in 67percent of patients and at least 20/20 in 96 percent (with the remaining refractive error caused by uncorrected astigmatism). Preoperative sphere was between -2.50 D and -11.00 D (mean -5.86; SD 2.92). BCVA declined by one line in a single eye; the patient subsequently was referred for investigation of nyctalopia and possible retinal dystrophy.

Among eyes with nearly two years follow-up, no incidence of cataract or any other significant complication has been observed, Dr. Parkhurst said.

“We do still worry, though, about the longer term risk of cataract and of endothelial cell loss because these patients are mostly very young,” he said. “The FDA age frame for the ICL is 21 to 45, and in this study the average age was 30.”
Complications included: 4.8 percent occasional glare or haloes, none causing functional impairment; one case of iritis; one case of nyctalopia; and three explants (one for excessive vault, two for wrong IOL power.

Dr. Parkhurst said he believes these initial results support use of the ICL, at minimum, to correct myopia in the 10 to 12 percent of soldiers he sees who are not candidates for excimer laser correction. But he expects more and more patients with lower levels of refractive error to choose the ICL, especially after a toric version becomes available.

“We’re in an environment where out-of-pocket cost to the patient is not an issue. The active-duty personnel who come in here pay for their surgery with service to their country,” he said. “There’s no financial incentive here to use one technology over another. A surprising number of them choose the ICL, because they like the idea of a technology that’s more reversible.”

CONFLICT OF INTEREST DECLARATION: Dr. Parkhurst has no financial interest in any of the products mentioned in this article.
REFERENCE 1. McCauley MB, Anderson DM, Johnson AJ. Posterior chamber Visian implantable collamer lens: stability and evaluation following traumatic grenade explosion. J Refract Surg. 2008 Jun;24(6):648-51.

Dr Goldberg had to apply for and receive special clearance from the FDA to perform a rare corrective surgery using a custom designed Aniridia lens implant.  The Aniridia lens is only approved by the FDA for compassionate use, and is reserved for trauma surgeries where damage to the iris is so severe, traditional methods of corrective surgeries can not be considered.   

According to Dr Goldberg, the patient suffered from malignant glaucoma in her right eye, which caused damage to her iris and rendered her legally blind in that eye.  To correct her vision, Goldberg implanted the custom designed Aniridia Lens and performed a corneal transplant.  The surgery was a remarkable success, and the patient has since had vision restored to her right eye. 

Dr Goldberg is one of a handful of eye surgeons who are skilled in implanting a custom designed Aniridia Lens.  Goldberg says that most doctors will never use this technique in their practice because of the process involved to gain clearance and the rarity of such severe eye diseases.  As an experienced corneal transplant surgeon, Dr Goldberg has extensive experience in rehabilitating desperately damaged eyes and was confident he could help her.  “Nothing else would have worked for her, and I knew we could greatly improve her vision with this procedure,” said Goldberg. 

To learn more about laser vision correction, visit Dr Goldberg’s website at http://www.goldberg4lasik.com/

About Dr Daniel Goldberg

Dr. Daniel Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery.  As a member of the elite team of doctors who performed clinical trials of LASIK in its early stages, Dr Goldberg was named by other eye physicians as one of the best doctors in America.  His initial research and findings led to the FDA approval of LASIK. Dr Goldberg has 25 years of experience in refractive surgery and has performed over 10,000 LASIK surgery procedures.  He recently became the first New Jersey eye surgeon to use the implantable contact lens (ICL) – a new technology to correct nearsightedness in individuals with extremely high prescriptions. 

More information on Dr Goldberg is available at http://www.goldberg4lasik.com/about-dr-goldberg/

The Visante® Omni is the first system to combine OCT and Placido disk technologies, which creates a new dimension in corneal and anterior segment evaluation.   The new technology will result in better screening for abnormal corneas as well as enable him to provide more accurate counseling regarding candidacy for laser vision correction.

Visante OCT delivers valuable pre- and post-surgical information for use in excimer laser surgery and corneal transplants as well as pre-and post-glaucoma surgical care and phakic IOL implantations. The OCT will image intraocular lens implants and aid in diagnosis of proper intraocular lens size and position.

To learn more about NJ LASIK Surgery options, visit Dr Goldberg’s website at http://www.goldberg4lasik.com/

 Crystalens is an accommodating intraocular lens that, unlike a standard IOL, can treat both a person’s cataracts and presbyopia, providing a range of vision from distance to near without glasses.  The unique Crystalens can reduce or eliminate glasses for most activities, including: reading a book, working on the computer, and driving a car.

 Dr Daniel Goldberg is the Director of Laser Surgery at the Atlantic Laser Vision Center and is a pioneer in the field of laser vision correction.  He has skilled expertise in advanced Cataract and Corneal surgery and can offer alternative solutions for vision correction, like Crystalens, when a patient is not a candidate for LASIK.

 As a member of the elite team of doctors who performed clinical trials of LASIK in its early stages, Dr Goldberg’s initial research and findings led to the FDA approval of LASIK. Dr Goldberg has 25 years of experience in refractive surgery and has performed over 10,000 LASIK surgery procedures.  He recently became the first New Jersey eye surgeon to use the implantable contact lens (ICL) – a new technology to correct nearsightedness in individuals with extremely high prescriptions. 

To learn more about Dr. Goldberg and the Atlantic Laser Vision Center, consumers can visit http://www.goldberg4lasik.com

Dr Daniel Goldberg performed the corneal transplant surgery at a greatly reduced fee, which was paid with funding provided by the Lions Club.  Middletown Lions Club Chairman Al Siano presented Goldberg with an award honoring his gracious contribution. “Our practice at Atlantic Eye Physicians is about helping others .  It is a blessing to all of us to be able to provide the gift of sight,” said Goldberg.

 Dr. Goldberg is a renowned expert and pioneer in laser vision correction, advanced cataract surgery and corneal transplantation..  He operates a cornea, cataract and laser vision surgery center in Little Silver, Atlantic Eye Physicians has offices in Long Branch, Little Silver and Holmdel.

 Currently Dr Goldberg is leading a worldwide study testing the effectiveness of using 5% Betadine irrigation for the treatment of acute EKC- a common, worldwide, highly contagious and often severe form of conjunctivitis with the potential for long term visual impairment due to corneal involvement. 

 To learn more about Dr Daniel Goldberg, visit http://www.refractivesurgerynj.com .

About the Middletown Township Lions Club

 The Middletown Township Lions Club, established in 1946, is part of Lions International and is a service organization which supports health and vision screenings, eye hospitals, youth-based programs, food pantries, and charitable causes and organizations like Camp Happiness, part of the New Jersey Blind Citizens’ Association, Leonardo.

Information on charitable programs, events, and membership in the Middletown Lions Club is available by contacting Lori Anne Oliwa, “Lion Shining Star,” at 732-757-7443 or via email at laoliwa@yahoo.com.

Dr. Daniel B Goldberg, Director of Refractive/LASIK Surgery, at The Atlantic Laser Vision Center in Little Silver, NJ  has a long-standing commitment to providing the most advanced technology for all his procedures, and that’s a great asset for potential patients.  Dr. Goldberg has completed over 10,000 Lasik procedures in New Jersey and a top choice for lasik eye surgery in the state.

Under Dr. Goldberg’s leadership, the Atlantic Laser Vision Center in Little Silver has continued to upgrade its lasers to provide the latest technologies and the best results.  The facility is the first in New Jersey, and one of the first in the US to combine the Intralase Femtosecond all-laser, no-blade flap with the VISX customized Excimer laser platform. 

“Our system now has been revised to integrate all of the new technology,” Goldberg says, “we have continued to bring the very best LASIK technologies to New Jersey which benefits our patients with safer and more accurate results.”  The the latest addition of iris registration theVISX S4 registers the treatment more accurately while delivering more precise customized treatment.  

The new AMO technologies qualify the facility as one of only a few centers in New Jersey certified to perform iLASIK.  iLASIK is a proprietary procedure performed on American Medical Optic’s (AMO) best equipment—WaveScan, Intralase, and VISX S4 with iris registration and FDA approved custom monovision.  In 2007 the FDA approved customVue monovision, which is part of the iLASIK platform.  Now all of these technologies—WaveScan, Intralase, VISX S4, and CustomVue monovision have been combined by AMO as iLASIK.  As further evidence of the advantages of this technology, the US Air Force, US Navy, and NASA have chosen the iLASIK platform for their pilots and astronauts.  All of these major advancements will result in safer, more exact laser vision correction results for patients at the Atlantic Laser Center in Little Silver, New Jersey.  

Dr. Goldberg helped introduce the use of IntraLase® in New Jersey, knowing it represented an extraordinary leap in refractive surgery. IntraLase® is more precise and safe than a microkeratome, or mechanical blade, in the critical first step of LASIK: creating the corneal flap. Replacing the microkeratome with IntraLase® gives LASIK patients a critical added safety factor.  Now, New Jersey LASIK patients have a safer, more precise alternative to the tiny handheld blade used by most to create the flap.

If you would like to schedule a consultation with Dr. Goldberg, please contact Gail Cerone our Laser Vision Coordinator .  You can reach Gail at 866-853-3263 or via email at gailcer1@gmail.com

Castle Connolly Medical Ltd. is a healthcare research and information company founded in 1991. Their goal is to help guide consumers to America’s top doctors and top hospitals using a detailed survey and comprehensive research

Dr Goldberg’s award recognizes him as one of the best doctors in the field of Ophthalmology. Dr Goldberg is credited as one of the first laser eye surgeons to help bring advanced technologies in the field to the United States. Dr. Daniel Goldberg has a rare dual certification from both the Council for Refractive Surgery Quality Assurance (an independent, nonprofit, patient and consumer health organization that evaluates and verifies the quality of the surgeries provided by select refractive surgeons in the United States), and the ABES( American Board of Eye Surgeons ). Nationwide, there are less than 10 LASIK surgeons with dual certification by ABES and CRSQA.

Dr Goldberg was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK. In 2000, at the ASCRS(American Society of Cataract and Refractive Surgeons) national meeting, the first large scale study of LASIK monovision was presented by Goldberg and the published paper appeared in 2001 in the Journal of Cataract and Refractive Surgery. Further research by Goldberg resulted in another large study of LASIK monovision which was published in 2003—this work compared results in far-sighted eyes as well as near-sighted eyes. Based on this research, Goldberg made presentations at national meetings on “Succeeding with LASIK Monovision” and taught courses at the ASCRS meetings on “Surgical correction of Presbyopia.”

In April of 2008, Dr Goldberg was recognized at the inaugural training session for Custom Vue Monovision in Chicago for helping to set the stage for the FDA approval of LASIK monovision.

For more information, visit www.goldberg4lasik.com

Dr. Daniel Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery.  He was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK.  

Dr Goldberg has 25 years of experience in refractive surgery and has performed over 10,000 LASIK surgery procedures.  He recently became the first New Jersey eye surgeon to use the implantable contact lens (ICL) – a new technology to correct nearsightedness in individuals with extremely high prescriptions. 

In 2008, Dr Goldberg was also recently honored by Castle Connolly Medical who presented him with their annual ‘Top Doctor” award which recognizes him as one of the best doctors in the field of Ophthalmology.  Then, in April of 2008, Dr Goldberg was again recognized at the inaugural training session for Custom Vue Monovision in Chicago for helping to set the stage for the FDA approval of LASIK monovision.

Dr Goldberg is constantly on the forefront of groundbreaking technology and innovations in the field of Ophthalmology.  Currently Dr Goldberg is leading a worldwide study testing the effectiveness of using 5% Betadine irrigation for the treatment of acute EKC- a common, worldwide, highly contagious and often severe form of conjunctivitis with the potential for long term visual impairment due to corneal involvement.  Ophthalmologists around the world are invited to register to participate in the Betadine for EKC study and can do so by visiting http://www.betadineforekc.com/submission-process.aspx.   

More information on Dr Daniel Goldberg is available at http://www.goldberg4lasik.com/

The purpose of the new study is to confirm the effectiveness of this protocol and to expand the awareness amongst eye care professionals of this inexpensive treatment for EKC. 

 The treatment of EKC using betadine has been widely debated for years, but new research is shedding positive light on the treatment.  The Ocular Surgery News website, www.osnsupersite.com, recently interviewed Dr Goldberg about his new study and about using betadine as a treatmentn for EKC.

To read the full interview and article on the Ocular Surgery News website, visit http://www.osnsupersite.com/view.aspx?rid=41471

Participation in the study is open to ophthalmologists, US and international, who agree to follow the protocol and report clinical results thru the Betadine for EKC website (http://www.betadineforekc.com/Default.aspx ). The initial phase will be collecting data thru October 1, 2009, and it is anticipated that subsequently there will be modifications to the protocol and study design.

For more information about the new study, please visit http://www.betadineforekc.com/the-study.aspx

Information on registration is available at http://www.betadineforekc.com/submission-process.aspx

Dr. Daniel B Goldberg, Director of Refractive/LASIK Surgery, at The Atlantic Laser Vision Center in Little Silver, NJ  has a long-standing commitment to providing the most advanced technology for all his procedures, and that’s a great asset for potential patients.

The Atlantic Laser Center uses the WaveScan Wavefront analyzer which can more accurately customize Excimer laser treatments.  The WaveScan is estimated to be 25X more accurate than measurements with lenses used in eyeglasses and contact lenses.  Dr. Goldberg states that “the results with customized LASIK have elevated the quality of results, and the results with all-laser Femtosecond laser flaps have elevated both the safety and the quality of results.  We have reached a new level in LASIK.”

Dr. Goldberg helped introduce the use of IntraLase® in New Jersey, knowing it represented an extraordinary leap in refractive surgery. IntraLase® is more precise and safe than a microkeratome, or mechanical blade, in the critical first step of LASIK: creating the corneal flap. Replacing the microkeratome with IntraLase® gives LASIK patients a critical added safety factor.  Now, New Jersey LASIK patients have a safer, more precise alternative to the tiny handheld blade used by most to create the flap.

In addition, the Atlantic Laser Center in Little Silver has continued to upgrade its lasers to provide the latest technologies and the best results.  The facility is the first in New Jersey, and one of the first in the US to combine the Intralase Femtosecond all-laser, no-blade flap with the VISX customized Excimer laser platform.  “Our system now has been revised to integrate all of the new technology,” Goldberg says, “we have continued to bring the very best LASIK technologies to New Jersey which benefits our patients with safer and more accurate results.”  The the latest addition of iris registration theVISX S4 registers the treatment more accurately while delivering more precise customized treatment.

The new technologies qualify the facility as one of only a few centers in New Jersey certified to perform iLASIK.  iLASIK is a proprietary procedure performed on American Medical Optic’s (AMO) best equipment-WaveScan, Intralase, and VISX S4 with iris registration and FDA approved custom monovision.  In 2007 the FDA approved customVue monovision, which is part of the iLASIK platform.  Now all of these technologies-WaveScan, Intralase, VISX S4, and CustomVue monovision have been combined by AMO as iLASIK.  As further evidence of the advantages of this technology, the US Air Force, US Navy, and NASA have chosen the iLASIK platform for their pilots and astronauts.  All of these major advancements will result in safer, more exact laser vision correction results for patients at the Atlantic Laser Center in Little Silver, New Jersey.

For more information, please visit www.lasiksurgery-nj.com

About Dr. Goldberg

Dr. Daniel B Goldberg is a comprehensive refractive surgeon – both a pioneer of LASIK surgery in the U.S. and an accomplished corneal and cataract surgeon.   Dr. Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery.  With 30 years of experience in refractive surgery, Dr. Goldberg has performed over 10,000 LASIK eye surgery procedures. Based in Monmouth County, New Jersey, Dr. Goldberg has performed LASIK on patients worldwide and was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK.

Dr Goldberg was the first to bring many technological advances in LASIK to benefit patients in New Jersey.  In 1990 he travelled to London and Stockholm to prepare for the FDA approvals for Excimer laser treatment of nearsightedness.  Initially, treatment for nearsighted eyes was performed on the surface of the cornea in a procedure called PRK (photo-refractive keratectomy).  In the mid 90′s, a new procedure-LASIK was developed.  Dr Goldberg was asked to participate in the CRS Study of LASIK which led to FDA approval.

Today, technology is steadily evolving and there are approximately 1.4 million LASIK procedures performed each year in the US.   The Atlantic Laser Vision Center is now equipped with the leading technologies used in laser vision correction.  Testing is performed with WaveScan and Orbscan to qualify patients as good candidates for LASIK, and the treatments are performed with the Intralase Femtosecond laser to perform a no-blade, all-laser treatment, and the Excimer laser treatment is then performed with computerized custom treatments on the VISX S4 Excimer laser with iris registration, tracking, and Fouriere-domain Wavescan driven custom treatments.  To learn more about these procedures, visit www.lasiksurgery-nj.com .

Dr Goldberg is excited about the future of laser vision correction at the Atlantic Laser Vision Center, and is proud to have brought together the team and the technology to be the leading LASIK center in our region.  Goldberg says, “We are delighted to reach the milestone of 10000 procedures and look forward to providing the best laser vision correction in our region.”

The evolution of comprehensive refractive surgery is opening new doors to those who were once told that better vision through LASIK surgery was not an option for them.  A comprehensive refractive surgeon can perform all aspects of vision correction including cornea remodeling and cataract surgery.  These procedures may help provide relief and enhanced vision under circumstances when LASIK cannot.

A Comprehensive Refractive Surgeon has skilled expertise in advanced Cataract and Corneal surgery and can offer alternative solutions for vision correction when LASIK has been ruled out.  Vision correction through refractive surgery can be achieved through:

• Laser Vision Correction
• Refractive Cataract Surgery
• Implantable Contact Lens (Visian ICL)
• Multifocal and Accommodating IOLs (ReStor and Crystalens)
• Monovision with IOLs or Laser Vision Correction
• Advanced Astigmatism Options (Toric IOLs and Corneal Relaxing Incisions)
• INTACS for Keratoconus

Consumers considering vision correction through surgery should consult with a comprehensive refractive surgeon who is skilled in the broad spectrum of refractive surgery.  There are many options available for individuals with thin corneas, cataracts and severe astigmatism.  A comprehensive refractive surgeon can help decide which procedure is best.

New Jersey residents who are not candidates for LASIK vision correction are encouraged to visit the office of Dr. Daniel Goldberg, a Comprehensive Refractive Surgeon who is also is one of the top corneal and cataract surgeons in New Jersey. 

Dr. Daniel Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery.  As a member of the elite team of doctors who performed clinical trials of LASIK in its early stages, Dr Goldberg was named by other eye physicians as one of the best doctors in America.  His initial research and findings led to the FDA approval of LASIK. Dr Goldberg has 25 years of experience in refractive surgery and has performed over 10,000 LASIK surgery procedures.  He recently became the first New Jersey eye surgeon to use the implantable contact lens (ICL) – a new technology to correct nearsightedness in individuals with extremely high prescriptions.

Reason #1: Dr. Daniel Goldberg

Dr. Daniel B Goldberg is a comprehensive refractive surgeon – both a pioneer of LASIK surgery in the U.S. and an accomplished corneal and cataract surgeon. Dr. Daniel Goldberg is one of less than 10 LASIK eye surgeons to hold a rare dual certification from both the Council for Refractive Surgery Quality Assurance (CRSQA) and the ABES (American Board of Eye Surgeons).

Reason #2: Practice Makes Perfect

When it comes to perfection, no one scores higher then Dr. Goldberg. With over 30 years of experience and more than 10,000 LASIK eye surgery procedures performed, Dr. Goldberg is setting the standard for expertise in LASIK eye surgery in the US. He feels that surgical certification of actual surgical results and not just knowledge is vital to a patient’s safety and quality of results. Although it is not mandatory, Dr. Goldberg voluntarily validates the results of his surgeries through ABES and CRSQA as part of a service to his patients to demonstrate his expertise and commitment to safety in laser eye surgery.

Reason #3: The Most Advanced Technology

The Atlantic Laser Vision Center in Little Silver is committed to providing the best environment and the best technology for laser vision correction. The center continues to upgrade its lasers to provide the latest technologies and the best results. The Atlantic Laser Vision Center is the first in New Jersey, and one of the first in the US, to combine the Intralase femtosecond all-laser, no-blade flap with the VISX customized excimer laser platform. The center also uses the WaveScan Wavefront analyzer. The WaveScan is estimated to be 25X more accurate than measurements with lenses used in eyeglasses and contact lenses. All of these technology advances result in safer, more accurate laser vision correction results for patients at the Atlantic Laser Center in Little Silver.

Reason #4: You’re In Good Company

The staff at the Atlantic Laser Vision Center is there for one reason only; YOU! Our professional and caring staff members are here to assist you in any way possible. You won’t find abrupt or discourteous staff members here. Our staff’s time is dedicated to ensuring you receive the best treatment and have the most enjoyable experience possible. Our time is devoted to you.

Reason #5: The Facility

Your comfort and satisfaction is our top priority. You can be sure that you are walking into a clean, comfortable and informative environment. To that end, we spare no expense in staff, equipment, or physical plant. We have two spacious waiting rooms for you and your family. Family members can watch the procedure exactly as the doctor sees it with powerful direct link technology equipped especially for them. It brings solace to those waiting for your procedure to be completed. This is just one of the many special touches we have added with your comfort in mind.

About Dr. Goldberg

Dr. Daniel B Goldberg is a comprehensive refractive surgeon – both a pioneer of LASIK surgery in the U.S. and an accomplished corneal and cataract surgeon. Dr. Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery. Based in Monmouth County, New Jersey, Dr. Goldberg has performed LASIK on patients worldwide and was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages.

As we age, our ability to change focus for near vision diminishes because the crystalline lens inside the eye becomes less flexible.  If the eye is nearsighted it may still be possible to read without glasses as we get older, but if the eye is not nearsighted or if vision is corrected for distance with glasses, contact lenses or LASIK, then we generally begin to need reading glasses after 40 years of age.

Eyeglasses, bifocals or progressive lenses provide clear focus for both near and distance vision.   With contact lenses there are several options for reading including bifocal contact lenses or mono-vision fitting of contact lenses.  Mono-vision is a strategy to correct both distance and near vision without wearing glasses, and it can be achieved with contact lenses or with Laser Vision Correction such as LASIK . 

With mono-vision, the dominant eye is generally corrected for distance vision and the non-dominant eye is corrected for near vision creating 2 eyes with different focus.

Despite nearly 40 years of experience with contact lens mono-vision, Dr. Goldberg recalls that in the 1990’s “when refractive surgery evolved with excimer laser vision correction, such as LASIK, into a safe and accurate surgical alternative to glasses or contact lenses, there was great skepticism about mono-vision amongst both eye surgeons and patients.”  This is because mono-vision breaks our concept of binocular vision with both eyes having similar focusing power.  Patients wondered if mono-vision would cause headaches and dizziness, and eye surgeons doubted the success and viability of surgical mono-vision.

Daniel B Goldberg MD at the Atlantic Laser Vision Center in Little Silver New Jersey was one of the pioneers in New Jersey laser vision correction, and developed a successful practice in refractive eye surgery in the 1990’s.  As he recalls: “Most of the research in refractive surgery at that time related to the development of the laser technology. Prior to my clinical research on mono-vision there were very few reports on surgical mono-vision and no reports on LASIK mono-vision at all.” 

In Dr. Goldberg’s practice, the patients over 40 years of age were seeking answers about correcting their reading vision without glasses.  In his practice, up to 50% of the patients over 40 chose mono-vision and the level of success and satisfaction was even higher that patients with contact lens mono-vision.

In 2000, at the ASCRS(American Society of Cataract and Refractive Surgeons) national meeting, the first large scale study of LASIK mono-vision was presented by Goldberg and the published paper appeared in 2001 in the Journal of Cataract and Refractive Surgery.  Further research by Goldberg resulted in another large study of LASIK mono-vision which was published in 2003—this work compared results in far-sighted eyes as well as near-sighted eyes.  Based on this research, Goldberg made presentations at national meetings on “Succeeding with LASIK Mono-vision” and taught courses at the ASCRS meetings on “Surgical correction of Presbyopia.”

Since 2003, there have been several additional studies by other experts on LASIK mono-vision which have confirmed the success previously reported by Goldberg.  Several months ago, the FDA approved the use of the VISX CustomVueExcimer Laser for LASIK mono-vision.  The VISX CustomVueexcimer laser is part of the advanced iLASIK surgical platform distributed by American Medical Optics, and CustomVueMono-vision is part of the iLASIK program.  NASA and the US Navy and Air Force have recently chosen this technology for LASIK on their pilots.  The Atlantic Laser Vision Center in Little Silver New Jersey is one of several centers in New Jersey offering iLASIK.

In April, at the inaugural training sesseion for CustomVueMonovison in Chicago, Goldberg was honored to be recognized for helping to set the stage for the FDA approval of LASIK mono-vision.  Goldberg feels that it was an opportunity of a lifetime to make a substantial contribution to his field:  “It is gratifying to see that LASIK mono-vision is now an accepted option for the surgical correction of presbyopia, and the FDA approval will enable more of our patients to safely enjoy greater freedom from glasses.”

The ABES(American Board of Eye Surgeons) promotes the highest possible quality ophthalmologic surgical care.  The ABES certification programs include a process through which a surgeon’s actual surgical skills and judgment are tested and observed by his or her peers.  The ABES tests surgical skills in cataract/intraocular lens surgery as well as LASIK and corneal transplantation.  In 1989, Dr Goldberg was the first eye surgeon in New Jersey to have surgical skills in cataract and intraocular lens surgery certified by ABES.  In 2002 he became one of 2 New Jersey LASIK surgeons to have surgical skills certified in LASIK by ABES.

The other organization to certify LASIK surgeons is the non-profit, patient advocacy CRSQA(Council of Refractive Surgery Quality Assurance).  According to CRSQA, certification is an important indication of the quality of a LASIK doctor, and once certified, results are re-evaluated every three months.  There are fewer than 250 doctors nationwide who have attained and maintain certification by CRSQA.

Nationwide, there are less than 10 LASIK surgeons with dual certification by ABES and CRSQA.  Daniel B.Goldberg MD of the Atlantic Laser Vision Center in Little Silver, NJ is the only NJ eye surgeon and one of only 10 eye surgeons nationwide to have dual certification in LASIK based on review of actual surgical skills and results.

Information on Dr. Daniel Goldberg and his practice is available at http://www.goldberg4lasik.com/

Laser Vision Correction, including LASIK and related procedures such as PRK(photorefractive keratectomy), and ASA(advanced surface ablation) have become the most common refractive surgical procedures with over 1.4 million procedures yearly in the US.  Steady advances in technology have contributed to the quality of results, and the safety of the procedure.

Consider the added safety of a femtosecond laser flap(e.g. Intralase all-laser LASIK or iLASIK) compared to blade LASIK with a microkeratome.  According to Dr. Goldberg, who is one of the first NJ eye surgeons to pioneer LASIK in New Jersey, and who also was one of the first to bring Intralase all-laser LASIK to the east coast:  “Safety is my top priority.  Using the best technology is part of the process, but proper patient selection and meticulous surgical technique is the key to success.”

The FDA scrutinizes and approves the safety of laser eye surgery technology.  Dr. Goldberg advises patients to seek the best combination of technology and an experienced surgical team.  He feels that surgical certification of actual surgical results is an important protection for patients:  “It demonstrates that the surgeon has the confidence to have their surgical skills and results evaluated.  I have always supported the principle that surgical skills and results should be evaluated objectively.”

Board certification by the American Board of Ophthalmology (ABO) is knowledge based but does not measure surgical skills.  Goldberg says:  “As a result, I continue to voluntarily validate my results thru ABES and CRSQA.  It is part of my service to patients to demonstrate our qualifications, and to protect their vision.”
About Dr. Goldberg

Abour Dr. Daniel Goldberg

Dr. Daniel B Goldberg is a comprehensive refractive surgeon – both a pioneer of LASIK surgery in the U.S. and an accomplished corneal and cataract surgeon.   Dr. Goldberg specializes in comprehensive refractive surgery including LASIK eye surgery and refractive intraocular lens and cataract surgery.  Based in Monmouth County, New Jersey, Dr. Goldberg has performed LASIK on patients worldwide and was a member of the elite team of doctors who performed clinical trials of LASIK in its early stages. This research led to FDA approval of LASIK.

Dr. Daniel B Goldberg, Director of Refractive/LASIK Surgery, at The Atlantic Laser Vision Center in Little Silver, NJ has a long-standing commitment to providing the most advanced technology for all his procedures, and that’s a great asset for potential patients. Dr. Goldberg has completed over 10,000 Lasik procedures in New Jersey and a top choice for lasik eye surgery in the state.

Under Dr. Goldberg’s leadership, the Atlantic Laser Vision Center in Little Silver has continued to upgrade its lasers to provide the latest technologies and the best results. The facility is the first in New Jersey, and one of the first in the US to combine the Intralase Femtosecond all-laser, no-blade flap with the VISX customized Excimer laser platform.

“Our system now has been revised to integrate all of the new technology,” Goldberg says, “we have continued to bring the very best LASIK technologies to New Jersey which benefits our patients with safer and more accurate results.” The the latest addition of iris registration theVISX S4 registers the treatment more accurately while delivering more precise customized treatment.

The new AMO technologies qualify the facility as one of only a few centers in New Jersey certified to perform iLASIK. iLASIK is a proprietary procedure performed on American Medical Optic’s (AMO) best equipment—WaveScan, Intralase, and VISX S4 with iris registration and FDA approved custom monovision. In 2007 the FDA approved customVue monovision, which is part of the iLASIK platform. Now all of these technologies—WaveScan, Intralase, VISX S4, and CustomVue monovision have been combined by AMO as iLASIK. As further evidence of the advantages of this technology, the US Air Force, US Navy, and NASA have chosen the iLASIK platform for their pilots and astronauts. All of these major advancements will result in safer, more exact laser vision correction results for patients at the Atlantic Laser Center in Little Silver, New Jersey.

Dr. Goldberg helped introduce the use of IntraLase® in New Jersey, knowing it represented an extraordinary leap in refractive surgery. IntraLase® is more precise and safe than a microkeratome, or mechanical blade, in the critical first step of LASIK: creating the corneal flap. Replacing the microkeratome with IntraLase® gives LASIK patients a critical added safety factor. Now, New Jersey LASIK patients have a safer, more precise alternative to the tiny handheld blade used by most to create the flap.

If you would like to schedule a consultation with Dr. Goldberg, please contact Gail Cerone our Laser Vision Coordinator . You can reach Gail at 866-853-3263 or via email at gailcer1@gmail.com

Source: CATARACT & REFRACTIVE SURGERY TODAY – FEBRUARY 2006

FACTORS INFLUENCING MONOVISION’S SUCCESS

Patients’ Expectations

The goal of monovision is to increase patients’ functional vision for daily tasks without the aid of glasses.
This endpoint, however, does not preclude a person’s ability to use glasses for tasks requiring clear binocular distance vision (ie, night driving) or sharp binocular near vision (ie, prolonged reading). Although some patients are satisfied with monovision, they face disadvantages such as less-than-ideal distance vision; the possible need for glasses when driving at night; two eyes, each focusing differently; and the adjustment involved with this form of correction.1-4

Ocular Dominance and Interocular Blur Suppression

Interocular blur suppression is essential to successful monovision. In each person, the input from one eye or the other is usually dominant in influencing binocular cells in the cerebral cortex. Information from an individual’s dominant eye produces a greater response to a given stimulus than input from his nondominant eye. Correcting the dominant eye for distance and the nondominant eye for near is standard, because (1) correcting the dominant eye for the most commonly used viewing distance maximizes blur suppression and (2) the dominant eye maximizes the performance of visual tasks requiring spatial perception.4

Although this approach is the norm in the studies reviewed for this article, Jain et al 4 reported that 43% of 42 study patients were treated with crossed monovision (wherein the dominant eye is corrected for near), and subjects’ satisfaction ranged from 72% to 86%. Although this range was relatively high, it was the lowest rate of patient satisfaction among the studies reviewed herein.

We’re excited to introduce you to the ultimate in laser vision correction, it’s called the iLASIK™ procedure and it’s the culmination of everything we’ve learned about LASIK over the past decade. Now that the iLASIK procedure is available, there’s really no reason to put off having laser vision correction surgery, because:

• Most people are candidates — make an appointment and have an exam
• iLASIK technology is advanced and innovative — so it’s safe and proven
• The iLASIK procedure is not complicated — it’s fast and virtually painless

The technology used in the iLASIK procedure is very mature and very safe. In fact, all branches of the U.S. military and NASA recently approved LASIK for their servicemen and women thanks to studies using iLASIK technology. Even better, the majority of people who are in good general health and who have stable vision are good candidates for the iLASIK procedure (it’s estimated that nearly 290 million people worldwide are good candidates for the iLASIK procedure).

So why don’t you take the next step to having the vision quality you’ve always dreamed of. Getting started is easy, simply schedule a consultation with us to determine if you are a good candidate. At your appointment, we’ll tell you more about the iLASIK procedure and review the great results people are having with this advanced vision correction technology.

Give us a call to schedule a free consultation. 1 (866) 853-3263